Search research articles
Contact Us
Filters
Showing results (31-40 of 106) with videos related to
Page
of 11
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 5, 2007
Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response
Gregory I S K Lau, Wings T Y Loo, Louis W C Chow
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
September 3, 2003
The study of cytokine dynamics at the operation site after mastectomy
Louis W C Chow, Wings T Y Loo, Kwok-Yung Yuen, et al.
Frontiers in Oncology
|
November 17, 2022
Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers
Christopher Y C Chow, Erich Ferdiansyah Lie, Cheng-Hsun Wu, et al.
Oncology Reports
|
April 6, 2006
Possible predictive markers related to micro-metastasis in breast cancer patients
Li Zhu, Wings T Y Loo, Carter W N Cheng, et al.
The International Journal of Biological Markers
|
February 17, 2015
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting
Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 5, 2007
Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro
Wings T Y Loo, J P Chen, Louis W C Chow, et al.
Life Sciences
|
May 3, 2003
A rat cell line derived from DMBA-induced mammary carcinoma
Louis W C Chow, Mary N B Cheung, Wings T Y Loo, et al.
Anticancer Research
|
August 10, 2002
Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients
Xi-Chun Hu, Weida Day, Brian Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: subgroup analysis from celecoxib antiaromatase neoadjuvant trial
Li Zhu, Louis W C Chow, Wings T Y Loo, et al.
Endocrine-Related Cancer
|
November 22, 2017
Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict's value
Louis W C Chow, Satoshi Morita, Christopher Y C Chow, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 106) with videos related to
Sort By:
Page
of 11
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 5, 2007
Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response
Gregory I S K Lau, Wings T Y Loo, Louis W C Chow
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
September 3, 2003
The study of cytokine dynamics at the operation site after mastectomy
Louis W C Chow, Wings T Y Loo, Kwok-Yung Yuen, et al.
Frontiers in Oncology
|
November 17, 2022
Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers
Christopher Y C Chow, Erich Ferdiansyah Lie, Cheng-Hsun Wu, et al.
Oncology Reports
|
April 6, 2006
Possible predictive markers related to micro-metastasis in breast cancer patients
Li Zhu, Wings T Y Loo, Carter W N Cheng, et al.
The International Journal of Biological Markers
|
February 17, 2015
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting
Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 5, 2007
Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro
Wings T Y Loo, J P Chen, Louis W C Chow, et al.
Life Sciences
|
May 3, 2003
A rat cell line derived from DMBA-induced mammary carcinoma
Louis W C Chow, Mary N B Cheung, Wings T Y Loo, et al.
Anticancer Research
|
August 10, 2002
Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients
Xi-Chun Hu, Weida Day, Brian Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: subgroup analysis from celecoxib antiaromatase neoadjuvant trial
Li Zhu, Louis W C Chow, Wings T Y Loo, et al.
Endocrine-Related Cancer
|
November 22, 2017
Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict's value
Louis W C Chow, Satoshi Morita, Christopher Y C Chow, et al.
Page
of 11